1
Phelps, Charles E. Health economics. 3rd ed. Boston, Mass: : Addison Wesley 2003.
2
Newhouse JP. Free for all? : lessons from the Rand Health Insurance experiment. New edition. Harvard University Press 1996:
3
Morris S. Economic analysis in health care. 2nd ed. Chichester: : John Wiley & Sons 2012.
4
Normand C. Economics, Health, And The Economics Of Health. BMJ: British Medical Journal;303:1572–7. doi:10.2307/29714045
5
Normand C. Economics, Health, and the Economics of Health. BMJ : British medical journal
British medical journal 1991;303:1572–7. doi:10.1136/bmj.303.6817.1572
6
Morris S. Economic analysis in health care. 2nd ed. Chichester: : John Wiley & Sons 2012.
7
Baker C. Hospital ownership, performance, and outcomes: assessing the state-of-the-science. Journal of Nursing Administration 2000;30:227–40.https://arlir.iii.com/nonret~S0&atitle=Hospital+ownership,+performance,+and+outcomes:+assessing+the+state-of-the-science&title=Journal+of+Nursing+Administration&aufirst=C.&auinit=&aulast=Baker&issn=00020443&eissn=15390721&coden=&volume=30&issue=5&spage=227&epage=240&quarter=&ssn=&date=2000&sid=&reqtype3
8
Becker GS, Murphy KM. A Theory of Rational Addiction. Journal of Political Economy 1988;96:675–700. doi:10.2307/1830469
9
Becker GS, Murphy KM. A Theory of Rational Addiction. Journal of Political Economy 1988;96:675–700.http://0-www.jstor.org.pugwash.lib.warwick.ac.uk/stable/1830469
10
Finkelstein A, McGarry K. Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market. The American Economic Review 2006;96:938–58. doi:10.2307/30034325
11
Finkelstein A, McGarry K. Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market. American Economic Review 2008;96:938–58.http://0-www.jstor.org.pugwash.lib.warwick.ac.uk/stable/30034325
12
Leonard KL. African traditional healers and outcome-contingent contracts in health care. Journal of Development Economics 2003;71:1–22. doi:10.1016/S0304-3878(02)00131-1
13
Newhouse JP. Medical-Care Expenditure: A Cross-National Survey. The Journal of Human Resources 1977;12:115–25. doi:10.2307/145602
14
Newhouse JP. Medical Care Expenditure: A Cross National Survey. The Journal of Human Resources 1977;12:115–25.http://0-www.jstor.org.pugwash.lib.warwick.ac.uk/stable/145602
15
Tussing AD, Wojtowycz MA. Physician-induced demand by Irish GPs. Social Science & Medicine 1986;23:851–60. doi:0277-9536(86)90213-3
16
Tussing AD, Wojtowycz MA. Physician-induced demand by Irish GPs. Social Science & Medicine 1986;23:851–60. doi:10.1016/0277-9536(86)90213-3
17
Morris S. Economic analysis in health care. 2nd ed. Chichester: : John Wiley & Sons 2012.
18
Blendon RJ, Schoen C, DesRoches C, et al. Common Concerns Amid Diverse Systems: Health Care Experiences In Five Countries. Health Affairs 2003;22:106–21. doi:10.1377/hlthaff.22.3.106
19
Cutler DM, Zeckhauser RJ. Adverse Selection in Health Insurance. NBER Working Papers doi:10.3386/w6107
20
Woolhandler S, Campbell T, Himmelstein DU. Costs of Health Care Administration in the United States and Canada. The New England journal of medicine 2003;349:768–75. doi:10.1056/NEJMsa022033
21
Woolhandler S, Campbell T, Himmelstein DU. Costs of Health Care Administration in the United States and Canada. The New England journal of medicine 2003;349:768–75. doi:10.1056/NEJMsa022033
22
Card D, Dobkin C, Maestas N. Does Medicare Save Lives? Quarterly Journal of Economics 2009;124:597–636. doi:10.1162/qjec.2009.124.2.597
23
Card D, Dobkin C, Maestas N. Does Medicare Save Lives? The Quarterly journal of economics 2009;124:597–636. doi:10.1162/qjec.2009.124.2.597
24
Cutler DM, Rosen AB, Vijan S. The Value of Medical Spending in the United States, 1960–2000. New England Journal of Medicine 2006;355:920–7. doi:10.1056/NEJMsa054744
25
Cutler DM, Rosen AB, Vijan S. The Value of Medical Spending in the United States, 1960-2000. The New England journal of medicine 2006;355:920–7. doi:10.1056/NEJMsa054744
26
Smith PC, Mossialos E, Papanicolas I, et al. Performance Measurement for Health System Improvement: Experiences, Challenges and Prospects. Cambridge: : Cambridge University Press 2010. http://0-dx.doi.org.pugwash.lib.warwick.ac.uk/10.1017/CBO9780511711800
27
Smith P. Performance measurement for health system improvement: experiences, challenges and prospects. Cambridge: : Cambridge University Press 2009. http://encore.lib.warwick.ac.uk/iii/encore/record/C__Rb2489399
28
Saffer H. Alcohol advertising bans and alcohol abuse: An international perspective. Journal of Health Economics 1991;10:65–79. doi:0167-6296(91)90017-H
29
Journal of health economics. http://webcat.warwick.ac.uk/search~S15?/tJournal+of+Health+Economics/tjournal+of+health+economics/1%2C2%2C3%2CB/frameset&FF=tjournal+of+health+economics&1%2C%2C2/indexsort=-
30
Propper C, Green K. A larger role for the private sector in financing UK health care: The arguments and the evidence. Journal of Social Policy 2001;30:685–704.http://0-journals.cambridge.org.pugwash.lib.warwick.ac.uk/article_S0047279401006444
31
Propper C, Green K. A Larger Role for the Private Sector in Financing UK Health Care: the Arguments and the Evidence. Journal of social policy 2001;30:685–704.http://0-journals.cambridge.org.pugwash.lib.warwick.ac.uk//article_S0047279401006444
32
Morris S. Economic analysis in health care. 2nd ed. Chichester: : John Wiley & Sons 2012.
33
Smith PC, Mossialos E, Papanicolas I, et al. Performance Measurement for Health System Improvement: Experiences, Challenges and Prospects. Cambridge: : Cambridge University Press 2010. http://0-dx.doi.org.pugwash.lib.warwick.ac.uk/10.1017/CBO9780511711800
34
Smith P. Performance measurement for health system improvement: experiences, challenges and prospects. Cambridge: : Cambridge University Press 2009. http://encore.lib.warwick.ac.uk/iii/encore/record/C__Rb2489399
35
Hirth RA, Chernew ME, Miller E, et al. Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard. Medical Decision Making 2000;20:332–42. doi:10.1177/0272989X0002000310
36
Hirth RA, Chernew ME, Miller E, et al. Willingness to Pay for a Quality-adjusted Life Year. Medical Decision Making 2000;20:332–42. doi:10.1177/0272989X0002000310
37
Nordhaus WD. The Health of Nations: The Contribution of Improved Health to Living Standards. NBER Working Papers Published Online First: 2002. doi:10.3386/w8818
38
Viscusi WK, Aldy JE. The Value of a Statistical Life: A Critical Review of Market Estimates throughout the World. NBER Working Papers Published Online First: 2003. doi:10.3386/w9487
39
Morris S. Economic analysis in health care. 2nd ed. Chichester: : John Wiley & Sons 2012.
40
Berwick DM, Weinstein MC. What Do Patients Value? Willingness to Pay for Ultrasound in Normal Pregnancy. Medical Care 1985;23:881–93. doi:10.2307/3764800
41
Hatziandreu E, Koplan J, Weinstein M, et al. A Cost-Effectiveness Analysis of Exercise as a Health Promotion Activity. American Journal of Public Health 1988;78:1417–23.http://0-search.ebscohost.com.pugwash.lib.warwick.ac.uk/login.aspx?direct=true&db=bth&AN=4687664&site=bsi-live
42
Hutton J, Brown RE. Use of Economic Evaluation in Decision Making: What Needs to Change? Value in Health 2002;5:65–6. doi:10.1046/j.1524-4733.2002.52115.x
43
Tengs TO, Adams ME, Pliskin JS, et al. Five-Hundred Life-Saving Interventions and Their Cost-Effectiveness. Risk Analysis 1995;15:369–90. doi:10.1111/j.1539-6924.1995.tb00330.x
44
O’brien B. Economic Evaluation of Pharmaceuticals: Frankenstein’s Monster or Vampire of Trials? Medical Care 1996;34:99–108. doi:10.2307/3766358
45
O’brien B. Economic Evaluation of Pharmaceuticals: Frankenstein’s Monster or Vampire of Trials? Medical Care 1996;34:DS99–108.
46
Schulman KA, Llana T, Yabroff KR. Economic Assessment within the Clinical Development Program. Medical Care 1996;34:89–95. doi:10.2307/3766357
47
Schulman KA, Llana T, Yabroff KR. Economic Assessment within the Clinical Development Program. Medical Care 1996;34:DS89–95.http://0-www.jstor.org.pugwash.lib.warwick.ac.uk/stable/3766357
48
Walley T, Haycox A. Pharmacoeconomics: basic concepts and terminology. British Journal of Clinical Pharmacology 1997;43:343–8. doi:10.1046/j.1365-2125.1997.00574.x
49
Walley T, Haycox A. Pharmacoeconomics: Basic Concepts and Terminology. British journal of pharmacology 1997;43:343–7.https://dx.doi.org/10.1046%2Fj.1365-2125.1997.00574.x
50
Cox [et al.] BD, Health Promotion Research Trust. The Health and lifestyle survey: preliminary report of a nationwide survey of the physical and mental health, attitudes and lifestyle of a random sample of 9,003 British adults. London: : Health Promotion Research Trust 1987.
51
Foster M, Jones AM. The Role of Tobacco Taxes in Starting and Quitting Smoking: Duration Analysis of British Data. In: Discussion Papers in Economics. The University of York-Department of Economics and Related Studies: 2001. http://www.york.ac.uk/media/economics/documents/discussionpapers/2000/0051.pdf
52
Cutler DM, McClellan M. Is Technological Change In Medicine Worth It? Health Affairs 2001;20:11–29. doi:10.1377/hlthaff.20.5.11
53
Cutler DM, Richardson E. The Value of Health: 1970-1990. The American Economic Review;88:97–100. doi:10.2307/116900
54
Cutler DM, Richardson E. The Value of Health: 1970-1990. American Economic Review 1998;88:97–100.http://0-www.jstor.org.pugwash.lib.warwick.ac.uk/stable/116900
55
Hickson K. The GDP Value of Twentieth-Century Health Improvements in Developed Economies: Initial Estimates for England. Review of Income and Wealth 2012;60:385–99. doi:10.1111/j.1475-4991.2012.00524.x
56
Nordhaus WD. The Health of Nations: The Contribution of Improved Health to Living Standards. NBER Working Papers Published Online First: 2002. doi:10.3386/w8818
57
Oeppen J, Vaupel JW. Broken Limits to Life Expectancy. Science;296. doi:10.2307/3076677
58
Oeppen J, Vaupel JW. Broken Limits to Life Expectancy. Science 2002;296:1029–31.http://0-www.jstor.org.pugwash.lib.warwick.ac.uk/stable/3076677
